How CKD is tested on Step 1

Expect a patient on dialysis or with long-standing diabetes and questions about lab patterns (calcium, phosphate, PTH, hemoglobin) and the mechanism of each complication.

Falling GFRG1GFR β‰₯ 90 with kidney damageG2GFR 60–89 with kidney damageG3a / G3bGFR 45–59 / 30–44G4GFR 15–29: plan for kidney replacementG5GFR < 15: kidney failure
GFR categories (mL/min/1.73 mΒ²). KDIGO also stages albuminuria: A1 < 30, A2 30–300, A3 > 300 mg/g.

Causes and progression

Whatever the cause, loss of nephrons leads surviving nephrons to hyperfilter, which injures them in turn.

CauseClue
Diabetic nephropathyAlbuminuria, retinopathy; nodular glomerulosclerosis
Hypertensive nephrosclerosisLong-standing hypertension; hyaline arteriolosclerosis
GlomerulonephritisHematuria, RBC casts, proteinuria
Autosomal dominant polycystic kidney diseaseBilateral enlarged cystic kidneys, family history, berry aneurysms
Obstruction or refluxRecurrent infections, scarring

Broad waxy casts in the sediment reflect dilated, damaged tubules of advanced CKD.

Nephron lossAny causeOverworkSurvivorshyperfilterGlomerularpressureRisesSclerosisMore nephron loss
Self-perpetuating injury. ACE inhibitors and ARBs dilate the efferent arteriole and lower glomerular pressure.

CKD-mineral bone disorder

Mineral disturbances begin early and are a favorite lab-pattern question.

↓ GFRPhosphateretained↓CalcitriolLess1Ξ±-hydroxylase↓ CalciumLess gutabsorption↑ PTHParathyroidsrespondBonediseaseRenalosteodystrophy
CKD-MBD. FGF23 rises early to promote phosphate excretion and further suppresses calcitriol.
LabSecondary hyperparathyroidism (CKD)Primary hyperparathyroidism
CalciumLow or normalHigh
PhosphateHighLow
PTHHighHigh
CalcitriolLowHigh or normal

Treatment: dietary phosphate restriction, phosphate binders, calcitriol or analogs, and calcimimetics (cinacalcet).

Other complications

Each complication traces to a lost kidney function.

CKD complicationsEndocrine↓ EPO β†’ anemia; ↓calcitriolExcretoryUremia, ↑ K⁺, ↑phosphateAcid-baseMetabolic acidosisVolumeHypertension, edema
Lost functions. Early CKD acidosis is usually non-anion gap; advanced CKD adds an anion gap from retained anions.
ComplicationMechanismTreatment
AnemiaLow erythropoietin; iron deficiency; shortened RBC survivalIron, then erythropoiesis-stimulating agent
Uremic bleedingPlatelet dysfunction (impaired adhesion)Desmopressin, dialysis
Uremic pericarditisRetained toxins; friction rub, often no ECG changesDialysis
HyperkalemiaReduced potassium excretionDiet, binders, dialysis
Cardiovascular diseaseHypertension, vascular calcification, dyslipidemiaBP control, statins

Uremic symptoms usually appear only when GFR is very low.

Slowing progression and a worked example

Treatment targets blood pressure, albuminuria, and complications, then kidney replacement.

  • ACE inhibitor or ARB for albuminuric CKD (expect a small creatinine rise; stop if it rises sharply).
  • SGLT2 inhibitors slow CKD progression in patients with and without diabetes.
  • Avoid nephrotoxins: NSAIDs, unnecessary contrast; adjust renally cleared drug doses.
  • Kidney replacement: hemodialysis, peritoneal dialysis, or transplantation (best long-term survival).
functions Worked example β€” lab pattern

A patient on hemodialysis has bone pain. Labs: calcium 8.0 mg/dL, phosphate 7.2 mg/dL, PTH markedly elevated, alkaline phosphatase elevated. Explain the pattern.

  1. Low GFR retains phosphate, and low calcitriol reduces calcium absorption.
  2. Low calcium and high phosphate stimulate the parathyroids.
  3. PTH rises (secondary hyperparathyroidism) and drives bone resorption.
  4. High bone turnover raises alkaline phosphatase and causes renal osteodystrophy (osteitis fibrosa cystica).

Answer. Secondary hyperparathyroidism from CKD-mineral bone disorder, causing renal osteodystrophy.